[PRLD] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
30-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY-
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 -
PBT -121,832 -115,438 -111,694 -56,929 -27,570 -14,680 52.65%
Tax 0 -8,102 -915 336 210 295 -
NP -121,832 -107,336 -110,779 -56,929 -27,570 -14,680 52.65%
Tax Rate - - - - - - -
Total Cost 121,832 107,336 110,779 56,929 27,570 14,680 52.65%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -2.02 -2.27 -2.33 -1.30 -0.85 -0.46 34.41%
EPS Diluted -2.02 -2.27 -2.33 -1.30 -0.85 -0.46 34.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.